Page results
-
Information about staff who work in the Macmillan Support and Information Service.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Advice on socialising and managing friendships for young people living with fatigue syndromes.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
The Upper GI service provides treatment for, amongst other conditions, oesophageal and gastric cancers as well as for benign conditions (acid reflux and motility disorders). There is close collaboration with the GI physiology and laser centre.
-
Komal Khuti-Dullaart is one of more than 300,000 patients using MyCare UCLH, our app and online service to help manage patient care.
